DUBLIN, Ohio--(BUSINESS WIRE)--Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB) and its subsidiary, Macrophage Therapeutics, Inc., today announced that four presentations of Manocept™ data from Kaposi’s Sarcoma (KS) studies are scheduled at the 18th International Workshop on Kaposi's Sarcoma Herpesvirus (KSHV) and Related Agents in Hollywood, Florida from June 30 - July 3, 2015. This research highlights a very likely new approach to the origin of KS supported by preclinical and clinical imaging studies.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.
